Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | KDM6B | O15054 | 1/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | KDM5C | P41229 | 1/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.40 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4099032 | 0.78 | KDM4E (0.56) | L3MBTL1KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL7735744 | 0.78 | L3MBTL1 (0.49) | L3MBTL1KDM4ECYP2C19RAB9ANPC1 | |
| SCHEMBL21552512 | 0.70 | KDM4E (0.56) | L3MBTL1KDM4ECYP2C19CYP46A1NEK2 | |
| SCHEMBL4847559 | 0.70 | NEK2 (0.51) | L3MBTL1KDM4ECYP2C19GSK3BDYRK1A | |
| SCHEMBL2274636 | 0.68 | KDM4E (0.66) | L3MBTL1KDM4ECYP2C19LMNASMN1; SMN2 | |
| SCHEMBL8136030 | 0.67 | KDM4E (0.51) | L3MBTL1KDM4EKDM6BKDM4AKDM5C | |
| SCHEMBL1299138 | 0.67 | ALDH1A1 (0.60) | KDM4ERAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL3259257 | 0.65 | HPGD (0.63) | KDM4ERAB9ANPC1LMNASMN1; SMN2 | |
| Dipyridyl SCHEMBL18601618 | 0.65 | KDM4E (0.74) | L3MBTL1KDM4EKDM6BKDM4AKDM5C | |
| Dipyridyl SCHEMBL2792069 | 0.65 | KDM4E (0.74) | L3MBTL1KDM4EKDM6BKDM4AKDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10219730-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2019-03-05 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-9320467-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140364710-A1 | Redox Polymers | THERASENSE, INC. | 2014-12-11 | — | — | US | disclosed |
| US-8828204-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-8795490-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-8512534-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2013-08-20 | — | — | US | disclosed |
| US-8444834-B2 | Redox polymers for use in analyte monitoring | ABBOTT DIABETES CARE INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-8268143-B2 | Oxygen-effect free analyte sensor | ABBOTT DIABETES CARE INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-20120132525-A1 | REDOX POLYMERS FOR USE IN ANALYTE MONITORING | ABBOTT DIABETES CARE INC. | 2012-05-31 | — | — | US | disclosed |
| US-20100288634-A1 | Transition Metal Complexes with Bidentate Ligand Having an Imidazole Ring | ABBOTT DIABETES CARE INC. | 2010-11-18 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-7090756-B2 | Controller for redox system | THERASENSE INC. (US) | 2006-08-15 | — | — | US | disclosed |
| EP-1230249-B1 | TRANSITION METAL COMPLEXES WITH BIDENTATE LIGAND HAVING AN IMIDAZOLE RING | THERASENSE INC (US) | 2004-06-02 | — | — | EP | disclosed |
| US-20040040840-A1 | Controller for redox system | THERASENSE, INC. | 2004-03-04 | — | — | US | disclosed |
| US-6605201-B1 | Charge transfer compounds comprising osmium compounds coupled to polymers, used as biosensors | THERASENSE, INC. | 2003-08-12 | — | — | US | disclosed |
| EP-1230249-A1 | TRANSITION METAL COMPLEXES WITH BIDENTATE LIGAND HAVING AN IMIDAZOLE RING | Therasense, Inc. (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001036430-A1 | TRANSITION METAL COMPLEXES WITH BIDENTATE LIGAND HAVING AN IMIDAZOLE RING | THERASENSE, INC. (US) | 2001-05-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | LPO, TXN2, PRDX5 | L3MBTL1 3476/4885KDM4E 1493/4885KDM6B 1705/4885 |
| US-20040040840-A1 | Controller for redox system | OTC, ME3, PPOX | L3MBTL1 3745/4885KDM4E 1472/4885KDM6B 2345/4885 |
| US-10219730-B2 | Redox polymers | PPOX, OTC, ME3 | L3MBTL1 3698/4885KDM4E 2030/4885KDM6B 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.